1Award AT, el-Husseini G, Anwar M, et al. Bilateral primary, breast cancers:a Clinicopathological study of the second primary. [ J ]. Int Surg, 1996,81(1):57.
2Kollias J, Ellias IO, Elston CW, et al. Prognostic significance of synchronous and metachronous bilateral breast cancer [J]. World J Surg, 2001,25(9) : 1117.
3Adler DD, Carson PL, Rubin JM, el al. Dopple ultrasound color flow imaging in the study of breast cancer: Preliminary findings [ J]. Ultrasound Medbiol, 1990, 16(6) :553.
4MetcalfeKA, GoelV, Lickley L, et al. Prophylactic bilateral mas-tectomy: patterns of practice[ J ]. Cancer, 2002,95 : 236.
3Cranenbroek S,van der Sangen M J, Kuijt GP, et al. Diagno- sis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients[ J]. Breast Cancer Res Treat,2005,89(3 ) :271.
4Anderson BO, Cazap E, E1 Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-re- source countries:executive summary of the Breast Health Global Initiative consensus, 2010 [ J ]. Lancet Oncol, 2011, 12(4) :387.
5Adler DD, Carson PL, Rubin J M, et al. Doppler ultrasound color flow imaging in the study of breast cancer:preliminary findings [ J ]. Ultrasound Med Biol, 1990,16 (6) : 553.
6Smith IE. Continuous infusional chemotherapy for early br- east cancer:the royal marsden hospital experience [ J]. Re- cent Results Cancer Res, 1998,15 (2) :323.
7Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast Cancer[ J]. Ann ned,2000,32( 1):43.
8Honkoop AH, Bakker SAL, Hoekman K, et al. Prolonged neoadju-vant chemotherapy with GM-CSF in locally ad- vanced breast cancer [ J ]. Oneologist, 1999,4 ( 1 ) : 106.
9Anderson BO,Cazap E,El Saghir NS,et al.Optimisation ofbreast cancer management in low-resource and middle-re-source countries:executive summary of the Breast HealthGlobal Initiative consensus,2010〔J〕[].The Lancet Oncology.2011
